Item 8.01. Other Events.
On October 12, 2007, Cougar Biotechnology, Inc. (the "Company") issued
a press release relating to results from its ongoing Phase I and Phase II
clinical trials of the Company's investigational drug CB7630 (abiraterone
acetate). A copy of the press release is attached hereto as Exhibit 99.1 and is
incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. Description
------------- ----------------------------------------------------------------
99.1 Press release dated October 12, 2007
|
Add
CGRB to Portfolio
Set Alert
Email to a
Friend